Alzheimer’s disease Archives - Express Pharma

Biomarkers becoming important for approval of ALS therapies: GlobalData

Exploring new avenues to treat Alzheimer’s

When proteins get stuck at solid: Unlocking the secrets to brain diseases

Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease

USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment

Biogen gets US FDA accelerated approval for Aduhelm to treat Alzheimer’s

Re-purposed drugs could reverse blood vessel damage in diabetes

US FDA approves first drug to image Tau Pathology in Alzheimer’s Disease related cases

IIT Guwahati discovers new ways to prevent memory loss due to Alzheimer

Novartis in global partnership with Amgen